Gilead Sciences
GILD
1,522 hedge funds and large institutions have $72.7B invested in Gilead Sciences in 2018 Q2 according to their latest regulatory filings, with 76 funds opening new positions, 544 increasing their positions, 725 reducing their positions, and 107 closing their positions.
0.04% more ownership
Funds ownership: 78.96% → 79% (+0.04%)
3% less funds holding
Funds holding: 1,563 → 1,522 (-41)
6% less capital invested
Capital invested by funds: $77.5B → $72.7B (-$4.82B)
22% less funds holding in top 10
Funds holding in top 10: 60 → 47 (-13)
25% less repeat investments, than reductions
Existing positions increased: 544 | Existing positions reduced: 725
29% less first-time investments, than exits
New positions opened: 76 | Existing positions closed: 107
31% less call options, than puts
Call options by funds: $1.25B | Put options by funds: $1.82B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$995M |
| 2 |
Bank of New York Mellon
New York
|
+$229M |
| 3 |
N
Natixis
Paris,
France
|
+$132M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$121M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$119M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$361M |
| 2 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
-$297M |
| 3 |
Goldman Sachs
New York
|
-$243M |
| 4 |
Renaissance Technologies
New York
|
-$161M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$125M |
GILD Hedge Fund Activity: Q2 2018 in Review
1,522 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q2 2018, worth a combined $72.7B — down 6.2% from $77.5B a quarter earlier.
Sellers outnumbered buyers: 107 funds closed out of GILD and 76 opened new positions — a net loss of 31 holders — while 725 trimmed existing stakes and 544 added.
The largest buyer was Capital Research Global Investors, adding an estimated $995M. The largest seller was Fidelity Investments, cutting an estimated $361M.
- 1,522 institutional investors held Gilead Sciences (GILD) as of Q2 2018, down from 1,563 in Q1 2018.
- Funds reported $72.7B of Gilead Sciences stock for Q2 2018, down 6.2% quarter-over-quarter.
- 76 funds opened new Gilead Sciences positions in Q2 2018 and 107 closed out, a net change of -31 holders.
- The largest Gilead Sciences buyer in Q2 2018 was Capital Research Global Investors, an estimated $995M added.
- The largest Gilead Sciences seller in Q2 2018 was Fidelity Investments, an estimated $361M sold.
Based on aggregated 13F filings for Q2 2018.